BB
BB Biotech Portfolio holdings
AUM
$3.98B
1-Year Return
15.06%
This Quarter Return
-27.59%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$2.52B
AUM Growth
-$1.03B
(-29%)
Cap. Flow
+$33.4M
Cap. Flow
% of AUM
1.33%
Top 10 Holdings %
Top 10 Hldgs %
75.05%
Holding
30
New
–
Increased
10
Reduced
1
Closed
1
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$10.1M |
| 2 |
Incyte
INCY
|
$6.52M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$4.01M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$3.69M |
| 5 |
Cidara Therapeutics
CDTX
|
$3.56M |
Top Sells
| 1 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$3.67M |
| 2 |
PTC Therapeutics
PTCT
|
$773K |
Sector Composition
| 1 | Healthcare | 86.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
26
DELISTED
Clovis Oncology, Inc.
CLVS
| $10.1M | 0.4% |
528,188
| – | – |
|
|
ACHN
27
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $9.88M | 0.39% |
1,279,340
| – | – |
|
|
28
Cidara Therapeutics
CDTX
$1.65B
| $9.49M | 0.38% |
37,341
+14,007
| +60% | +$3.56M |
|
|
29
PTC Therapeutics
PTCT
$4.61B
| $7.62M | 0.3% |
1,182,912
-120,000
| -9% | -$773K |
|
|
TTPH
30
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| – | – |
-18,310
| Closed | -$3.67M |
|